We are live on
!
Find out more
VCM
Versant Capital Management Portfolio holdings
AUM
$1.12B
1-Year Est. Return
34.21%
This Fund
S&P 500
This Quarter
Est. Return
+13.52%
1 Year Est. Return
+34.21%
3 Year Est. Return
+82.39%
5 Year Est. Return
+89.4%
10 Year Est. Return
+245.39%
AUM
$1.12B
AUM Growth
+$101M
(+10%)
Cap. Flow
+$19.1M
Cap. Flow
% of AUM
1.71%
Top 10 Holdings %
Top 10 Hldgs %
31.56%
Holding
2,873
New
96
Increased
1,181
Reduced
859
Closed
128
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DXUV
Dimensional US Vector Equity ETF
DXUV
|
+$8.37M |
| 2 |
Dimensional Emerging Markets Core Equity 2 ETF
DFEM
|
+$7.66M |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$6.75M |
| 4 |
DXIV
Dimensional International Vector Equity ETF
DXIV
|
+$4.35M |
| 5 |
Dimensional Emerging Markets Value ETF
DFEV
|
+$2.47M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$2.11M |
| 2 |
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
|
+$2.02M |
| 3 |
Vanguard Total Stock Market ETF
VTI
|
+$1.88M |
| 4 |
CoreCivic
CXW
|
+$1.84M |
| 5 |
Apple
AAPL
|
+$1.34M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.06% |
| 2 | Financials | 7.05% |
| 3 | Industrials | 6.04% |
| 4 | Consumer Discretionary | 4.74% |
| 5 | Healthcare | 4.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
Acadia Pharmaceuticals
ACAD
$4.25B
| $23.7K | ﹤0.01% |
936
+328
| +54% | +$7.22K |
|
1852
TPG
TPG
$6.87B
| $23.6K | ﹤0.01% |
581
-46
| -7% | -$1.93K |
|
1853
Kimberly-Clark
KMB
$36.4B
| $23.5K | ﹤0.01% |
214
-346
| -62% | -$34.3K |
|
1854
Amplify Junior Silver Miners ETF
SILJ
$3.27B
| $23.5K | ﹤0.01% |
907
+375
| +70% | +$11.1K |
|
|
AAT
1855
American Assets Trust
AAT
$1.49B
| $23.4K | ﹤0.01% |
948
-206
| -18% | -$4.52K |
|
1856
Darling Ingredients
DAR
$9.93B
| $23.4K | ﹤0.01% |
428
-29
| -6% | -$1.73K |
|
1857
Century Aluminum
CENX
$4.57B
| $23.4K | ﹤0.01% |
508
-4
| -0.8% | -$241 |
|
1858
First Busey Corp
BUSE
$2.52B
| $23.3K | ﹤0.01% |
791
| – | – |
|
|
CCRN
1859
DELISTED
Cross Country Healthcare
CCRN
| $23.3K | ﹤0.01% |
1,760
+953
| +118% | +$11.3K |
|
1860
Edgewell Personal Care
EPC
$1.27B
| $23K | ﹤0.01% |
856
+595
| +228% | +$12.7K |
|
1861
Trade Desk
TTD
$8.13B
| $22.9K | ﹤0.01% |
1,265
-10,163
| -89% | -$216K |
|
1862
MDU Resources
MDU
$4.44B
| $22.9K | ﹤0.01% |
1,078
| – | – |
|
1863
Akamai
AKAM
$16.8B
| $22.8K | ﹤0.01% |
193
+7
| +4% | +$872 |
|
1864
Camping World
CWH
$363M
| $22.7K | ﹤0.01% |
2,973
-449
| -13% | -$3.25K |
|
1865
Vanguard Short-Term Bond ETF
BSV
$44.6B
| $22.7K | ﹤0.01% |
291
-74
| -20% | -$5.78K |
|
1866
Brady Corp
BRC
$4.45B
| $22.6K | ﹤0.01% |
247
+141
| +133% | +$11.7K |
|
1867
Lazard
LAZ
$4.37B
| $22.6K | ﹤0.01% |
539
+527
| +4,392% | +$24.1K |
|
1868
South Plains Financial
SPFI
$841M
| $22.5K | ﹤0.01% |
523
+126
| +32% | +$5.26K |
|
1869
Miller Industries
MLR
$586M
| $22.5K | ﹤0.01% |
440
| – | – |
|
1870
SiteOne Landscape Supply
SITE
$4.43B
| $22.4K | ﹤0.01% |
196
+182
| +1,300% | +$22K |
|
1871
Zscaler
ZS
$23B
| $22.3K | ﹤0.01% |
158
+25
| +19% | +$3.49K |
|
1872
Installed Building Products
IBP
$6.13B
| $22.3K | ﹤0.01% |
97
+56
| +137% | +$13.6K |
|
1873
PagerDuty
PD
$700M
| $22.3K | ﹤0.01% |
2,307
-10,222
| -82% | -$77.4K |
|
1874
NWPX Infrastructure Inc
NWPX
$1.25B
| $22.2K | ﹤0.01% |
148
| – | – |
|
1875
Fluence Energy
FLNC
$1.78B
| $22.1K | ﹤0.01% |
1,114
-120
| -10% | -$2.23K |
|
Similar funds
FLAM
AIM
MTCM
CNC
NOSC
RIM
ACG
C
Versant Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Versant Capital Management held 2,873 positions worth $1.12B, up 10% from $1.01B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Versant Capital Management's Q2 2026 filing shows 96 new, 1,181 increased, 859 reduced and 128 closed positions. Its largest new stake was AstraZeneca: 7,263 shares worth $1.36M. The largest sale was iShares 3-7 Year Treasury Bond ETF, an estimated $2.11M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Industrials.
- Versant Capital Management's largest Q2 2026 buy was AstraZeneca: 7,263 shares worth $1.36M.
- Versant Capital Management added most to Dimensional US Vector Equity ETF in Q2 2026, an estimated $8.37M increase.
- Versant Capital Management's biggest Q2 2026 reduction was iShares 3-7 Year Treasury Bond ETF, cutting an estimated $2.11M.
- Versant Capital Management fully exited iShares 5-10 Year Investment Grade Corporate Bond ETF in Q2 2026, selling an estimated $2.02M.
- Versant Capital Management's ten largest holdings make up 32% of its $1.12B portfolio in Q2 2026.
- Versant Capital Management opened 96 new positions and closed 128 in Q2 2026.
- Versant Capital Management's portfolio value rose 10% quarter-over-quarter to $1.12B.
Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.